Lipids and α-Synuclein: adding further variables to the equation.

Area of Science:

• Neuroscience
• Biochemistry
• Molecular Biology

Background:

• Alpha-Synuclein (αSyn) aggregation is a hallmark of synucleinopathies, including Parkinson's disease (PD), dementia with Lewy Bodies (DLB), and multiple system atrophy (MSA).
• αSyn's interaction with cell membranes, particularly negatively charged phospholipids, is crucial for its function and implicated in aggregation.
• Alterations in lipid metabolism and membrane composition are increasingly recognized as factors influencing αSyn aggregation and neurodegeneration.

Purpose of the Study:

• To review current knowledge on lipid changes associated with αSyn aggregation in neurodegenerative diseases.
• To discuss the bidirectional relationship between cellular lipid composition and αSyn aggregation.
• To highlight knowledge gaps regarding lipid changes during physiological aging and regional brain differences.

Main Methods:

• Literature review synthesizing findings on αSyn, lipid metabolism, and neurodegeneration.
• Analysis of studies investigating the role of membranes in αSyn aggregation.
• Examination of research on genetic factors, aging, and their influence on lipid-brain interactions.

Main Results:

• αSyn aggregation can be triggered by membranes and can itself alter cellular lipid profiles.
• Genetic risk factors for PD and DLB are often linked to proteins involved in lipid metabolism.
• Patient brain samples exhibit altered lipid compositions, suggesting a complex interplay.

Conclusions:

• A reciprocal relationship likely exists between cellular lipid composition and αSyn aggregation, influenced by genetics, environment, and aging.
• Further research is needed to understand age-related lipid changes and regional brain lipid variations.
• Elucidating these lipid dynamics is critical for understanding synucleinopathies and developing therapeutic strategies.